Compare Kawasan Industri Jababeka Tbk. (KIJA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kawasan Industri Jababeka Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Kawasan Industri Jababeka Tbk. trades at Rp197 (market cap 3.96T, 426.54M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Kawasan Industri Jababeka Tbk. is far larger — about 37.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| KIJA | SCPI | |
|---|---|---|
Market Cap | 3.96T | 104.4B |
Volume | 426.54M | — |
Lot | 4.27M | — |
Turnover | 83.21B | — |
Average Price | 195.09 | — |
Value | 83.21B | — |
Indicative Equilibrium Price | 197 | — |
Indicative Equilibrium Volume | 118.64K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kawasan Industri Jababeka Tbk.
PT Kawasan Industri Jababeka Tbk (the Company) was established within the framework of the Domestic Capital Investment Law No.6 year 1968 which was amended by Law No.12 year 1970, based on notarial deed No.18 of Maria Kristiana Soeharyo, S.H., dated January 12, 1989. The Company started its commercial operations in 1990. The Companys shares are listed on JSX and SSX.
Read more on KIJA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
